ASCENTAGE PHARMA GROUP INTERNATIONAL
AAPG · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $38,317,514 | $8,705,479 | $7,901,715 | $7,027,351 |
| - Cash | $1,236,578 | $1,069,296 | $1,475,639 | $1,706,886 |
| + Debt | $1,668,497 | $1,795,595 | $1,792,727 | $1,084,290 |
| Enterprise Value | $38,749,433 | $9,431,778 | $8,218,803 | $6,404,755 |
| Revenue | $980,650 | $221,984 | $209,711 | $27,910 |
| % Growth | 341.8% | 5.9% | 651.4% | – |
| Gross Profit | $951,565 | $191,441 | $187,713 | $24,582 |
| % Margin | 97% | 86.2% | 89.5% | 88.1% |
| EBITDA | -$237,631 | -$743,610 | -$786,966 | -$798,335 |
| % Margin | -24.2% | -335% | -375.3% | -2,860.4% |
| Net Income | -$405,433 | -$925,637 | -$882,924 | -$782,424 |
| % Margin | -41.3% | -417% | -421% | -2,803.4% |
| EPS Diluted | -1.34 | -13.12 | -13.4 | -12.28 |
| % Growth | 89.8% | 2.1% | -9.1% | – |
| Operating Cash Flow | -$111,357 | -$726,077 | -$653,915 | -$604,679 |
| Capital Expenditures | -$24,289 | -$56,844 | -$236,963 | -$436,629 |
| Free Cash Flow | -$135,646 | -$782,921 | -$890,878 | -$1,041,308 |